This inventor holds 6 USPTO granted patents and 3 published patent applications and 5 EPO patents. Top assignee: Fresenius Kabi Oncology Limited. Active years: 2016-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Gurgaon, IN (2016 - 2018)
- Haryana, IN (2020 - 2024)
Company Filing History:
Years Active: 2016-2024
Title: The Innovative Journey of Rajesh Khanna: A Rising Star in Pharmaceutical Patents
Introduction
Rajesh Khanna, an accomplished inventor based in Gurgaon, IN, has made significant contributions to the pharmaceutical industry. With a total of six patents to his name, Khanna is known for his innovative approach to drug composition, particularly in the development of targeted therapies.
Latest Patents
Among his notable inventions are his recent patents related to pharmaceutical compositions comprising Afatinib. These inventions involve a unique tablet formulation that includes Afatinib or a pharmaceutically acceptable salt thereof. The tablets are obtained through a direct compression method, showcasing his commitment to enhancing drug delivery systems. Furthermore, the patents detail the processes for manufacturing these tablets and their intended uses, highlighting Khanna's thorough understanding of pharmaceutical engineering.
Career Highlights
Rajesh Khanna is currently associated with Fresenius Kabi Oncology Limited, where he has been pivotal in advancing oncology therapeutics. His work has not only contributed to the company's reputation in the pharmaceutical sector but also paved the way for innovative treatment alternatives for various types of cancers. His consistent efforts in research and development have earned him respect among his peers and the broader scientific community.
Collaborations
Throughout his career, Khanna has collaborated with talented individuals such as Dhiraj Khattar and Mukti Yadav, emphasizing the importance of teamwork in the complex world of pharmaceutical innovation. These collaborations have enabled him to leverage diverse expertise, driving forward the development of effective therapies.
Conclusion
Rajesh Khanna's journey as an inventor reflects his dedication and innovation in the field of pharmaceuticals. With six patents to his name, he is a valuable asset to Fresenius Kabi Oncology Limited and the medical community at large. His contributions continue to inspire and pave the way for future advancements in drug formulation and delivery.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile